Clinical trial
Conventional Versus Fractional CO2 Laser Assisted Photodynamic Therapy for Basal Call Carcinomas and Actinic Keratoses
NCT01260987 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Conventional Versus Fractional CO2 Laser Assisted Photodynamic Therapy for Basal Call Carcinomas and Actinic Keratoses
- Lead sponsor
- Bispebjerg Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- August 31, 2012
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratosis, basal cell carcinoma